Last update:
Medications news
Medications
Studies indicate no major concerns about risks to offspring for would-be dads taking epilepsy meds
Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to their offspring doesn't justify any major concerns, ...
11 hours ago
0
0
Health care app could help improve medication safety
Around 75% of Australians have experienced a bad reaction to a medication, but fewer than half have reported it to a doctor or the Therapeutic Goods Administration (TGA), a new survey has found.
14 hours ago
0
0
Why is it so hard to get drugs approved for use during pregnancy?
Nobody wants to see another Thalidomide tragedy.
18 hours ago
0
0
Survey shows 25% of adults consider weight loss drug use without prescription
Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is that some people are skipping the doctor's office and reaching out ...
Sep 17, 2024
0
0
Experimental drug helps cancer patients regain weight, study shows
Pfizer Inc.'s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, offering fresh promise for treating the dangerous muscle-wasting condition.
Sep 16, 2024
0
24
Ozempic could curb progression of diabetes-linked liver disease
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.
Sep 16, 2024
0
11
Targeted radioactive infusion for late-stage prostate cancer shown to improve outcomes for patients in earlier stages
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
Sep 16, 2024
0
0
Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain
A study from Mass General Brigham researchers provides evidence that large language models (LLMs), used for generative artificial intelligence (AI), ChatGPT-4 and Google's Gemini, demonstrated no differences in suggested ...
Sep 16, 2024
0
16
Team publishes results from clinical trial evaluating cabozantinib in advanced neuroendocrine tumors
The Alliance for Clinical Trials in Oncology today announced that final results will be presented at ESMO 2024 from CABINET (A021602), a phase III trial evaluating cabozantinib compared with placebo in two cohorts of patients ...
Sep 16, 2024
0
0
Researchers announce clinical trial results for hard-to-treat breast and bladder cancers
Professors Tom Powles and Peter Schmid recently delivered results from their phase three clinical trials during Sunday's Presidential Symposium to over 30,000 attendees at the European Society for Medical Oncology (ESMO) ...
Sep 16, 2024
0
0
Need medicine in hospital? Study finds how often IT flaws lead to the wrong drug or dose
Every time you are prescribed medicine in hospital, a computer will prompt your doctor about the appropriateness of the medicine and its dose.
Sep 14, 2024
0
3
Metformin found to reduce organ aging in male monkeys
A team of biologists affiliated with multiple institutions in China, working with a colleague in the U.S., has found that giving cynomolgus monkeys the diabetes drug metformin can reduce aging in multiple organs, including ...
Key factors identified that can impact long-term weight loss in patients with obesity prescribed GLP-1 RA medications
A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. ...
Sep 13, 2024
0
0
Antidepressants prescribed for pain in older adults despite weak evidence of effectiveness
University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on international guidelines that use limited evidence. The paper is published in the British Journal of Clinical ...
Sep 13, 2024
0
0
2017 to 2022 saw increase in naloxone prescribing among adolescents, research shows
From 2017 to 2022, there was an increase in naloxone prescribing among adolescents, with pediatricians accounting for an increasing proportion of prescriptions dispensed, according to a study published online Sept. 12 in ...
Sep 13, 2024
0
0
Which gut drugs might end up in a lawsuit? Are there really links with cancer and kidney disease?
Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a class action lawsuit in Australia.
Sep 12, 2024
0
1
Aussies with type 2 diabetes are missing out on crucial meds, says study
UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better protect them from heart and kidney disease—which are among the major causes of death for people ...
Sep 12, 2024
0
4
Reductions seen in benzodiazepine dispensing when states relax medical, recreational cannabis access
A small team of mental and public policy specialists from the Georgia Institute of Technology, the University of Georgia and Indiana University has found that when states relax or rescind laws governing the use of marijuana, ...
Drug delivery system targets chemo-induced hearing loss
The chemotherapy drug cisplatin is a lifesaver for many adults and children diagnosed with cancer, but it often causes hearing loss, a side effect that can diminish quality of life following treatment. To prevent hearing ...
Sep 11, 2024
0
1
Predictors for achieving, sustaining blood glucose control, weight loss with tirzepatide in adults with type 2 diabetes
The phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine (a long-acting insulin) for type 2 diabetes (T2D). Now new research examining ...
Sep 11, 2024
0
56
Tirzepatide associated with greater weight loss in women than men
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research ...
Sep 11, 2024
0
1
Semaglutide's cardiovascular benefits are maintained in people with impaired kidney function, research finds
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether ...
Sep 11, 2024
0
0
Large-scale population analysis confirms reassuring safety profile of tirzepatide
As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged. Now real-world evidence from the FDA Adverse Event ...
Sep 11, 2024
0
37
How do drugs like Ozempic work? And why are they on trial?
You don't often see a "science day" in a Philadelphia courtroom. But that's exactly what happened last week in a potentially ground-shifting legal fight brought by patients against the manufacturers of blockbuster drugs for ...
Sep 11, 2024
0
1
